Document Type

Plan B - Open Access

Award Date

2022

Degree Name

Master of Science (MS)

Department

Biology and Microbiology

First Advisor

Greg Heiberger

Abstract

Hepatic encephalopathy is a temporary decline in mental function that is often associated with liver disease and/or portal-systemic disease. Hepatic encephalopathy (HE) symptoms can range from minor cognitive declines to coma and are known to result from excess ammonia accumulations in the blood stream subsequent to liver failure. While HE is known to result from hepatobiliary disorder, many of the physiological process underlying its development and progression remain to be elucidated. Recent studies have identified neurological, metabolic, and microbiome changes implicated in the disease state of HE. In this review, the roles of traditional pharmaceutical interventions and newly developing understandings of the molecular biology underlying hepatic encephalopathy will be explored.

Number of Pages

20

Publisher

South Dakota State University

Rights

© 2022 Els Reuvekamp

Share

COinS